Complicated Urinary Tract Infection
📧 Sign up to get email alerts when something new happens for Complicated Urinary Tract Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales [Phase 3]
A Phase 3 clinical trial update reporting completion of studies evaluating Cefepime/Nacubactam and Aztreonam/Nacubactam vs best available th…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) [Phase 3]
Phase 3 trial comparing oral tebipenem pivoxil hydrobromide to intravenous imipenem-cilastatin in adults with complicated urinary tract infe…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants [Phase 2]
A Phase 2 study assessing safety, tolerability, and pharmacokinetics of cefiderocol in hospitalized pediatric participants has completed wit…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Clinical Performance Evaluation of the QIAstat-Dx® cUTI Plus AMR
The document reports on the clinical performance evaluation of the QIAstat-Dx cUTI Plus AMR diagnostic for complicated urinary tract infecti…
-
EMA approval · 2026-01-26EMA Authorised: Recarbrio (imipenem monohydrate;cilastatin sodium;relebactam monohydrate) — Merck Sharp & Dohme B.V.
EMA authorised Recarbrio (imipenem/cilastatin/relebactam) for use in Gram-negative bacterial infections, including hospital-acquired/ventila…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis [Phase 2]
Phase 2 study assessing safety, tolerability, and pharmacokinetics of meropenem-vaborbactam in children with complicated urinary tract infec…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children [Phase 4]
A Phase 4 clinical trial in children evaluating single-dose intravenous antibiotics for complicated urinary tract infections; recruitment is…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis [Phase 3]
Phase 3 results comparing cefepime/nacubactam or aztreonam/nacubactam against imipenem/cilastatin for complicated urinary tract infection an…
-
FDA approval · 2025-10-22FDA Approved: CONTEPO — Original Application (Meitheal Pharmaceuticals Inc.)
The FDA approved Contepo (fosfomycin disodium) from Meitheal Pharmaceuticals as a new intravenous antibiotic under NDA212271 for the treatme…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) [Phase 3]
A Phase 3 clinical trial evaluating cefepime-zidebactam (FEP-ZID) for complicated urinary tract infection and acute pyelonephritis has compl…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Clinical Utility of a PCR Compared to Culture and Sensitivity Testing for the Management of cUTI in Adults. [NA]
A completed clinical trial evaluated the clinical utility of PCR testing versus culture and sensitivity for managing complicated urinary tra…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea
Pfizer is conducting a post-market study in Korea to gather information about Zavicefta (ceftazidime-avibactam) after it was released, cover…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections [Phase 3]
Phase 3 trial is recruiting to assess efficacy and safety of meropenem plus pralubactam for carbapenem-resistant Enterobacteriaceae infectio…
-
FDA approval · 2025-06-23FDA Approved: MEROPENEM — Original Application (BROOKS STERISCIENCE LIMITED)
FDA approved the original application for a generic meropenem product manufactured by Brooks SterisScience Limited.
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Diagnosis, Antibiotic Prescribing Practices and Outcomes of cUTI in an Outpatient Setting
This completed clinical trial investigated diagnosis, antibiotic prescribing practices, and outcomes for complicated urinary tract infection…
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants [Phase 2]
Phase 2 pediatric study of cefiderocol in hospitalized children evaluating safety, tolerability, and pharmacokinetics has completed.
-
FDA approval · 2025-02-28FDA Approved: AVYCAZ — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for AVYCAZ (ceftazidime-avibactam) from Allergan, Inc., authorizing changes to the approved labeling…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: A Trial of HRS-8427 in the Treatment of Adults With Complicated Urinary Tract Infection, Including Acute Pyelonephritis [Phase 3]
HRS-8427 is being evaluated in a Phase 3 trial for adults with complicated urinary tract infection, including acute pyelonephritis, and is c…
-
CLINICAL_TRIALS research · 2024-08-14Clinical Trial Update: Expanded Access Use of Sulopenem Etzadroxil/Probenecid for Complicated Urinary Tract Infection
Expanded access for sulopenem etzadroxil/probenecid in complicated urinary tract infection and acute pyelonephritis is no longer available.
-
FDA approval · 2024-06-24FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium by Sandoz Inc to support changes to the approved gener…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Evaluating UTI Outcomes in at Risk Populations
Pathnostics completed a clinical trial evaluating outcomes of urinary tract infections in at-risk populations. The study assessed UTIs and c…
-
FDA approval · 2024-01-26FDA Approved: AVYCAZ — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for AVYCAZ (ceftazidime-avibactam) filed by Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: A Study to Investigate PK, Safety, Tolerability of Cefepime-enmetazobactam in Pediatric Participants With cUTI [Phase 2]
Phase 2 pediatric study assessing pharmacokinetics, safety, and tolerability of cefepime-enmetazobactam in children with complicated urinary…
-
FDA approval · 2023-12-11FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Devatis, Inc.)
FDA approved an Original Application for amoxicillin and clavulanate potassium (amoxicillin/clavulanate) as a generic antibiotic formulation…
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: A Trial of Intravenous HRS-8427 in the Treatment of Adults With Complicate Urinary Tract Infection, Including Acute Pyelonephritis [Phase 2]
Phase 2 clinical trial update for intravenous HRS-8427 in adults with complicated urinary tract infection, including acute pyelonephritis.